MAZE
Maze Therapeutics, Inc. · Healthcare · Market cap $1.8B
Insiders sold $6.1M net in the last 90 days ·4 sellers, 0 buyers· 10 of 18 sales under Rule 10b5-1 plans· latest Form 4 filed Oct 2, 2026
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$23.7M
reported sales (SEC code S)
Unique Insiders
6
in the rolling window
Latest filing
Oct 2, 2026
Coloma Jason V
Maze Therapeutics, Inc. (MAZE) has 50 SEC Form 4 filings (146 transaction rows) in the rolling window, disclosed by 6 distinct insiders. Most recent filing: Oct 2, 2026.
Inside the rolling window, 6 insiders at Maze Therapeutics, Inc. reported no open-market purchases and 53 open-market sales totaling $23.7M. The most active filer is President, R&D & CMO Bernstein Harold with 17 filings. Insiders have net sold $10.7M over the trailing 6 months. The most recent open-market filing is a sale of 34,501 shares by Chief Executive Officer Coloma Jason V, dated Oct 1, 2026, worth $932K.
- Industry:Biotechnology
- CEO:Jason Coloma
- Employees:141
- HQ:South San Francisco, CA, US
- IPO:2025-01-31
| Source | |||||||
|---|---|---|---|---|---|---|---|
| Chief Executive Officer | Sale | 34,501 | $932K | Oct 2 | +23.3% | SEC ↗ | |
| President, R&D & CMO | Sale | 16,141 | $435K | Oct 2 | +23.3% | SEC ↗ | |
| CSBO | Sale | 7,500 | $203K | Oct 1 | +22.3% | SEC ↗ | |
| President, R&D & CMO | Sale | 9,705 | $255K | Sep 8 | +23.5% | SEC ↗ | |
Courtney PhillipsFirst filing | GC and Corp. Secretary | Sale | 1,981 | $52K | Sep 4 | +24.3% | SEC ↗ |
Courtney PhillipsFirst filing | GC and Corp. Secretary | Sale | 2,012 | $52K | Sep 4 | +24.3% | SEC ↗ |
| Chief Executive Officer | Sale | 11,227 | $297K | Sep 4 | +24.3% | SEC ↗ | |
| Chief Executive Officer | Sale | 11,411 | $297K | Sep 4 | — | SEC ↗ | |
| CSBO | Sale | 3,191 | $84K | Sep 4 | — | SEC ↗ | |
| CSBO | Sale | 3,243 | $84K | Sep 4 | — | SEC ↗ | |
| President, R&D & CMO | Sale | 5,106 | $135K | Sep 4 | — | SEC ↗ | |
| President, R&D & CMO | Sale | 5,189 | $135K | Sep 4 | — | SEC ↗ | |
| Chief Executive Officer | Sale | 34,501 | $907K | Sep 3 | — | SEC ↗ | |
| President, R&D & CMO | Sale | 16,141 | $426K | Sep 3 | — | SEC ↗ | |
| CSBO | Sale | 7,500 | $207K | Aug 31 | — | SEC ↗ | |
| President, R&D & CMO | Sale | 16,142 | $446K | Aug 14 | — | SEC ↗ | |
| Chief Executive Officer | Sale | 34,501 | $922K | Aug 5 | — | SEC ↗ | |
| CSBO | Sale | 7,500 | $205K | Jul 31 | — | SEC ↗ | |
| Chief Executive Officer | Sale | 34,501 | $1.0M | Jul 2 | — | SEC ↗ | |
| President, R&D & CMO | Sale | 14,609 | $437K | Jul 2 | — | SEC ↗ | |
| CSBO | Sale | 7,500 | $210K | Jul 1 | — | SEC ↗ | |
| Chief Executive Officer | Sale | 3,993 | $104K | Jun 24 | — | SEC ↗ | |
| Chief Executive Officer | Sale | 23,865 | $622K | Jun 24 | — | SEC ↗ | |
| President, R&D & CMO | Sale | 14,853 | $381K | Jun 3 | — | SEC ↗ | |
| Chief Executive Officer | Sale | 6,643 | $174K | Jun 3 | — | SEC ↗ |
Earnings: last 7 quarters
Frequently asked questions
How many SEC Form 4 insider filings does MAZE have?
Maze Therapeutics, Inc. (MAZE) has 50 SEC Form 4 filings (146 transaction rows) in the rolling 365-day window, disclosed by 6 distinct insiders. Most recent filing: Oct 2, 2026.
When was the most recent SEC Form 4 filing for MAZE?
The most recent Form 4 filing for MAZE on Tracefour is dated Oct 2, 2026.
Who is the most active insider at MAZE?
The most active SEC Form 4 filer at MAZE in the rolling window is President, R&D & CMO Bernstein Harold, with 17 filings.
What is the net insider flow at MAZE over the last 6 months?
Over the trailing 180 days, insiders at MAZE have net sold $10.7M based on SEC Form 4 disclosures.
What is the total insider buy and sell value at MAZE in the current window?
Inside the rolling window, insiders at MAZE bought $0 and sold $23.7M based on SEC Form 4 filings.
Can I get alerts for MAZE insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at Maze Therapeutics, Inc. (MAZE). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
Maze Therapeutics, Inc. is in the Healthcare sector.